Showing results (281-290 of 1,919) with videos related to

Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|August 12, 2017
MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathwayLi-Li Mei, Yun-Tan Qiu, Meng-Bing Huang, et al.
Cancer Biomarkers : Section a of Disease Markers|August 12, 2017
MiR-513c suppresses neuroblastoma cell migration, invasion, and proliferation through direct targeting glutaminase (GLS)Hong-Liang Xia, Yao Lv, Chun-Wei Xu, et al.
Cancer Biomarkers : Section a of Disease Markers|August 12, 2017
An ensemble method integrated with miRNA expression data for predicting miRNA targets in stomach adenocarcinomaGuang-Wei Liu, Zhao-Min Qin, Qin-Hai Shen
Cancer Biomarkers : Section a of Disease Markers|November 25, 2017
Low-level serum miR-24-2 is associated with the progression of colorectal cancerH W He, N N Wang, X M Yi, et al.
Cancer Biomarkers : Section a of Disease Markers|November 25, 2017
Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancerDan Tan, Li Sheng, Qing-Hua Yi
Cancer Biomarkers : Section a of Disease Markers|October 25, 2017
Infiltration of γ⁢δ T cells, IL-17+ T cells and FoxP3+ T cells in human breast cancerRoni Allaoui, Catharina Hagerling, Eva Desmond, et al.
Cancer Biomarkers : Section a of Disease Markers|October 25, 2017
MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1Tonghai Huang, Guangsuo Wang, Lin Yang, et al.
Cancer Biomarkers : Section a of Disease Markers|September 5, 2017
Downregulation of Piwil3 suppresses cell proliferation, migration and invasion in gastric cancerLei Jiang, Wen-Jun Wang, Zhan-Wu Li, et al.
Cancer Biomarkers : Section a of Disease Markers|September 5, 2017
High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndromeWuping Li, Yun Zhong, Yuerong Shuang, et al.
Cancer Biomarkers : Section a of Disease Markers|September 5, 2017
IDH1 status is significantly different between high-grade thalamic and superficial gliomasMingrong Zuo, Mao Li, Ni Chen, et al.
Pageof 192